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The only way out of mitosis
The ubiquitination and destruction of cyclins provides the
way out of mitosis. A multiprotein complex polyubiquitinates
cyclin B and promotes the separation of sister chromatids.
Entry into, and exit from, mitosis is governed by the
activation and inactivation of cyclin-dependent kinase 1
(Cdkl, also known as p34cdc2; see [1] for review). The
activity of this kinase oscillates during the cell cycle
because cyclin B, an activating subunit of the kinase, is
stable in interphase and unstable in mitosis [2]. Cyclin
instability is mediated by a short sequence near the amino
terminus of the protein, the destruction box [3]. The
rapid, destruction-box-dependent proteolysis of cyclin B
in mitosis is essential for cell-cycle progression: deletion
of the destruction box stabilizes cyclin and prevents exit
from mitosis [4]. In both frog cell extracts and yeast cells,
non-degradable cyclins arrest cells in telophase, after sepa-
ration of the sister chromatids [5,6]. Several recent papers
[7-10] provide key insights into the mechanism of cyclin
degradation. An evolutionarily conserved multiprotein
complex, the anaphase-promoting complex, which con-
tains the products of the cell-cycle regulatory genes
CDC16, CDC23 and CDC27, as well as additional
factors, targets cyclin for destruction and promotes the
separation of sister chromatids at anaphase.
Cyclin is degraded by the ubiquitin protein-degradation
system [3]. This proteolytic pathway was elucidated
initially through studies of the proteolysis of denatured
proteins (see [11] for review). Proteins are marked for
destruction by becoming linked successively to a chain
of multiple ubiquitin subunits. The enzyme pathway
involved in conjugating ubiquitin to target proteins is
complex (Fig. 1). First, ubiquitin, a 7 kDa protein, is
activated at its carboxyl terminus (by an enzyme desig-
nated El) and transferred as a thioester intermediate to a
ubiquitin-conjugating enzyme (UBC). In the next step,
ubiquitin ligases generate an isopeptide bond between
the carboxyl terminus of ubiquitin and a lysine residue
within either a target protein or another previously con-
jugated ubiquitin molecule. In some cases, ubiquitin is
transiently linked to the ubiquitin ligase [12]. Proteins
carrying multiubiquitin conjugates are then proteolysed
by a large protein complex, the proteasome.
Until just recently, the enzymes that ubiquitinate cyclins
had not been identified. This gap has been filled by a
convergence of experiments performed with diverse
experimental systems: 'reverse genetics' (from DNA
sequence to protein to function) in human cells, bio-
chemical fractionation of egg extracts, and yeast genetics.
In one line of inquiry, Tugendreich et al. [7] character-
ized two human homologs of the yeast Saccharomyces cere-
visiae proteins, CDC16p and CDC27p. These proteins
contain a conserved motif, the tetratricopeptide repeat
(TPR), which mediates protein-protein interactions
[13]. In yeast, CDC16p, CDC23p and CDC27p (each of
which contains tandem TPRs) form a multiprotein com-
plex [13]. Partial sequences of the genes encoding the
human homologs, HsCDC16p and HsCDC27p, have
been identified in the database of 'expressed sequence
tags'. Antibodies raised against the human proteins were
used to localize the proteins to the mitotic spindle and
the centrosomes of human cells. Notably, microinjection
of antibodies against HsCDC27p prevented both exit
from metaphase and chromosome separation [7].
In the absence of a biochemical assay for the function of
the complex that contains CDC16p, CDC23p and
CDC27p, the role of these proteins in mitotic exit
remained a matter of speculation. Fortunately, the anti-
bodies raised against human CDC16p and CDC27p rec-
ognized their Xenopus homologs. King et al. [8] and
Sudakin et al. [10] had been fractionating extracts of
Xenopus and clam eggs, respectively, in an attempt to find
the components involved in ubiquitinating the amino ter-
minus of cyclin B. One fraction contained a large (20 S)
complex that was subject to mitotic regulation. Using the
antibodies against HsCDC16p and HsCDC27p, King et
al. [7] found that these proteins precisely cofractionated
with the 20 S complex. They also identified UBC4p as
one of the ubiquitin-conjugating enzymes for cyclin B.
The anti-HsCDC27p antibodies could be used to affin-
ity-purify the 20 S complex, and the system required for
cyclin ubiquitination could be reconstituted using defined
components: ubiquitin, ubiquitin-activating enzyme,
UBC4p and the CDC27p-containing complex. Interest-
ingly, the p34cdC2 /cyclin B kinase was not required in the
reconstituted system, provided that the CDC27p-con-
taining complex was derived from a mitotic egg extract.
Earlier work on S. cerevisiae had suggested that the
p34CDC2 8 /cyclin B complex (containing the budding
yeast homolog of p34cdc2) is not required to maintain
cyclin-destruction activity. In fact, in this species, the
cyclin-destruction pathway is activated in M phase (mito-
sis) but not inactivated until the G-phase cyclins,
CLNlp, CLN2p or CLN3p, accumulate [14]. This ena-
bled Irniger et al. [9] to arrest cells in G1 with their
cyclin-destruction activity turned on, and then to screen
for mutants defective in the destruction of a cyclin B-13-
galactosidase fusion protein. The mutations isolated in
this screen were in three previously identified essential
genes: CDC16, CDC23 and CSE1. Thus, this screen led
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Fig. 1. The life cycle of a cyclin.
to the same protein complex as the other two approaches.
Conditional alleles in each of the three genes are defective
in the degradation of cyclin B but are able to degrade
other short-lived proteins. Mutations in CDC16 and
CDC23 cause a cell-cycle arrest in which cells are large-
budded with a short spindle and unseparated chromo-
somes - an analogous phenotype to that caused by
microinjection of anti-HsCDC27 antibodies into Hela
cells. A clever genetic trick allowed Irniger et al. to
demonstrate that separation of chromatids itself requires
CDC23 activity, because cells mutant in this gene can
randomly segregate unreplicated chromosomes but cannot
segregate replicated chromosomes.
Thus CDC16p, CDC23p, and CDC27p and additional
factors form a complex required for both ubiquitination
of cyclin B and separation of sister chromatids: the com-
plex was therefore named the anaphase-promoting com-
plex (APC; Fig. 1). How widespread is APC function?
There is a discrepancy between the telophase-arrest phe-
notype of mutations in the destruction box of cyclin and
the metaphase-arrest phenotype of mutations in compo-
nents of the ubiquitinating machinery. This discrepancy
can be explained if the APC also ubiquitinates proteins
other than cyclin. According to one model, sister chro-
matids are held together by a protein which, at anaphase,
is proteolysed to allow sister chromatid separation [5].
This protein remains to be identified, and it may be a
regulatory protein rather than a structural one. Purifica-
tion of the APC and identification of mutations in the
genes encoding components of the complex will make
identification of other substrates feasible. It is likely that
candidate substrates for the APC will contain a destruction
box motif. Moreover, candidate substrates of the APC
may be discovered simply by sequence analysis revealing
the presence of a destruction box in a gene identified for
other reasons. If a substrate of the APC were specifically
required for the separation of sister chromatids, mutation
of the gene encoding it might lead to the 'cut' pheno-
type (cell untimely torn) that results when cytokinesis
occurs before complete nuclear division. A number of
mutants with this phenotype have already been identified
[15]; perhaps some of the genes defined by these muta-
tions encode other substrates of the APC. One other
substrate of the APC is known - cyclin A. Of the eight
subclasses of cyclins now known (designated A-H) only
A- and B-type cyclins contain destruction-box motifs
and both are ubiquitinated by the APC [10].
How is the APC regulated? The function of the APC is
to trigger the onset of anaphase by marking various pro-
teins for destruction by the proteasome. The complex
must therefore be carefully regulated so that anaphase
onset occurs only if the cell is ready for this irreversible
set of events - that is, if all chromosomes have bipolar
attachments to the spindle. On one level, the APC is
activated by p34dc2 /cyclin B, but this activation is proba-
bly indirect, as there is a substantial lag between activa-
tion of p34cdc2 /cyclin B and activation of cyclin degrad-
ation [16]. The APC is probably also subject to additional
levels of regulation, as certain substrates can be protected
from ubiquitination by the APC. For example, Irniger et
al. [9] provide evidence that, in certain mutants, a subset
of the cell's cyclin B is resistant to APC. Similarly, disrup-
tion of the mitotic spindle with drugs that affect the
microtubules allows cyclin A to be degraded but not
cyclin B. This may occur by sequestration or post-trans-
lational modification of one or other of the substrates.
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Why is the APC at centrosomes and in the mitotic
spindle? Localization of the APC to the mitotic spindle
may reflect the fact that some of its substrates are them-
selves localized there. For example, one of the B-type
cyclins is localized to microtubules [17,18]. In the early
cell cycles during Drosophila embryogenesis, it appears
that cell-cycle progression occurs in the absence of com-
plete destruction of all the cychin B - it appears that
cyclin is degraded only in the immediate vicinity of the
spindle. It is also possible that association of the APC
with the mitotic spindle and centrosomes regulates APC
activity. Finally, as the APC is required for the movement
of chromosomes at anaphase, it is attractive to speculate
that the complex is localized to the spindle in order to
ubiquitinate certain proteins that modulate microtubule
dynamics or microtubule motors.
Why does polyubiquitination of cyclin require a complex
of more than 1 000 kDa? Several other substrates of the
ubiquitin pathway (but not specifically of the APC) are
known, including the tumor suppressor gene p53, the
transcriptional regulators Matot2 and c-Jun, and the cell-
cycle regulators CLN2p and SIClp [19-23]. Polyubiqui-
tination of p53 has been reconstituted using purified
components: ubiquitin, a ubiquitin-activating enzyme,
UBC4p, the adenovirus protein E6 and its associated cel-
lular associated protein E6-AP [12,24]. In this case, E6
and E6-AP perform the same biochemical role as the
APC. Thus, the polyubiquitination reaction does not
absolutely require the large protein complex. But there
are differences between the polyubiquitination of cyclin
and that of p53 . Cychin ubiquitination results in a ladder
of conjugates that contain from 1 to 25 ubiquitins. The
abundance of these species decreases with increasing
numbers of ubiquitin subunits, indicating that the reac-
tion does not always proceed to completion. In contrast,
the polyubiquitination of p53 generates only highly con-
jugated products. Perhaps this difference in the reaction
products reflects an underlying difference in the structure
and processivity of the ubiquitinating machinery.
It is also interesting to compare the APC with the well-
characterized protein machine that degrades ubiquiti-
nated proteins. The proteasome is a cylindrical proteolytic
core complex (20 S) capped on each side by a 19 S com-
plex that gates the entry of proteins into the channel in
the core [25]. The structure of the 20 S core has been
solved: it looks like a molecular grinder with its proteo-
lytically active residues in the central core [26]. Perhaps
the APC is also a well-defined particle with a shape that
lends itself to the task of assembling isopeptide bonds
between ubiquitin and substrate.
The initial observation of the periodic destruction of
cyclin has provided important clues to the mechanisms of
both cell-cycle regulation and regulated protein degrada-
tion. Further study of the APC will unravel the multiple
ways in which the complex is regulated so that cell divi-
sion can occur with high fidelity. The identification of
other APC substrates will surely lead to new proteins that
play interesting roles in mitosis.
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